SEC Comment Letter 0000000000-24-007640 to IGTA Merger Sub Ltd (PRGY)
IGTA Merger Sub Ltd
Date: July 5, 2024 · CIK: 0001997698 · Accession: 0000000000-24-007640
AI Filing Summary & Sentiment
File numbers found in text: 333-276929
Show Raw Text
July 5, 2024
Cheuk Hang Chow
Chief Executive Officer
IGTA Merger Sub Ltd.
875 Washington Street
New York, NY 10014
Re:IGTA Merger Sub Ltd.
Amendment No. 3 to Registration Statement on Form S-4
Filed June 21, 2024
File No. 333-276929
Dear Cheuk Hang Chow:
We have reviewed your amended registration statement and have the following
comments.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments. Unless we note otherwise,
any references to prior comments are to comments in our May 14, 2024 letter.
Amendment No.3 to Registration Statement on Form S-4
Questions and Answers about the Business Combination and the Special Meeting
Q: Will I experience dilution..., page xiii
1.Please update your Potential Impact of Additional Dilution table to reflect the June 4,
2024 redemption of 1,686,707 shares of Inception Growth common stock.
AgileAlgo Management Revenue Update, page 86
2.We note your statement on page 86 that "there had been little to no lost deals in
AgileAlgo's pipeline and very minimal slips or no-decisions." Given that AgileAlgo did
not meet forecasted revenues because it was "not doing the required volume to meet the
revenue projected," please discuss how you determined that you had no lost deals, slips
and no-decisions.
July 5, 2024
Page 2
Selected Historical Financial Information of AgileAlgo, page 116
3.Please update to include the Balance Sheet data as of March 31, 2024 and Statement of
Operations and Statements of Cash Flow Data for the six-months ended March 31, 2024.
Management's Discussion and Analysis of Financial Condition and Results of Operations of
AgileAlgo
Results of Operations
Revenues, page 131
4.You state here that you expect the commencement of, at minimum, two new customer
projects under your new ADA line of business will close in June and August of 2024 and
each contract has a value of between $220,000 to $250,000. You further state on page 134
that as of the date of this proxy statement/prospectus, you are in the advanced stages of
negotiations for a project contract, which will be your inaugural project under the new
ADA line of business and range between $225,000 and $260,000. Please clarify whether
the two contracts discussed on page 131 are the same as the one discussed on page 134.
Also, revise to disclose how many contracts you closed to date or expect to close under
the new ADA line of business. Clarify whether any of ADA contracts have commenced,
and if not, disclose when you expect them to begin. Also, please clarify whether you
expect that all current and future ADA projects will have gross profit margins between
20% to 22%.
Unaudited Pro Forma Condensed Combined Financial Statements
Pro Forma Combined Balance Sheet, page 151
5.We note that cash and cash equivalents under the Maximum Redemption scenario is
($651,000). Please revise to reflect this balance as a liability. In addition, add a footnote
discussing how you intend to fund the negative cash balance should 100% of Inception
Growth's remaining shareholders redeem their shares. To the extent additional funding is
not probable, tell us how you determined your current presentation is appropriate.
Inception Growth Acquisition Limited Notes to Consolidated Financial Statements
General, page F-23
6.Please update the Report of Independent Registered Public Accounting Firm and
Subsequent Events footnote to be consistent with Inception Growth's Form 10-K/A filed
on June 3, 2024. In addition, revise to provide an updated auditor's consent in Exhibit 23.2
that reflects the corrected opinion dates.
July 5, 2024
Page 3
Please contact Chen Chen at 202-551-7351 or Kathleen Collins at 202-551-3499 if you
have questions regarding comments on the financial statements and related matters. Please
contact Mariam Mansaray at 202-551-6356 or Jan Woo at 202-551-3453 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc:Ted Paraskevas